NLRC3 — NLR Family CARD Domain Containing 3
<div class="infobox infobox-gene">
| Property | Value | [@conti2005] |
|----------|-------| [@kortmann2015] |
| Gene Symbol | NLRC3 |
| Full Name | NLR Family CARD Domain Containing 3 |
| Chromosomal Location | 16p13.3 |
| NCBI Gene ID | 81128 |
| OMIM ID | 611362 |
| Ensembl ID | ENSG00000167900 |
| UniProt ID | Q7RTV0 |
| Encoded Protein | NLR family CARD domain-containing protein 3 |
| Associated Diseases | Cancer, Inflammatory Conditions, Alzheimer's Disease, Parkinson's Disease |
</div>
Overview
NLRC3 (NLR Family CARD Domain Containing 3), also known as NLR family CARD domain-containing protein 3 or NOD3, is a member of the NOD-like receptor (NLR) family of proteins. Located on chromosome 16p13.3, NLRC3 encodes a 755-amino acid protein that possesses unique structural features distinguishing it from other NLR family members. Unlike classical NLR proteins such as [NLRP3](/genes/nlrp3) or [NLRC4](/genes/nlrc4), NLRC3 contains a TIR (Toll/Interleukin-1 Receptor) domain, placing it at the intersection of NLR and TLR signaling pathways.
...NLRC3 — NLR Family CARD Domain Containing 3
<div class="infobox infobox-gene">
| Property | Value | [@conti2005] |
|----------|-------| [@kortmann2015] |
| Gene Symbol | NLRC3 |
| Full Name | NLR Family CARD Domain Containing 3 |
| Chromosomal Location | 16p13.3 |
| NCBI Gene ID | 81128 |
| OMIM ID | 611362 |
| Ensembl ID | ENSG00000167900 |
| UniProt ID | Q7RTV0 |
| Encoded Protein | NLR family CARD domain-containing protein 3 |
| Associated Diseases | Cancer, Inflammatory Conditions, Alzheimer's Disease, Parkinson's Disease |
</div>
Overview
NLRC3 (NLR Family CARD Domain Containing 3), also known as NLR family CARD domain-containing protein 3 or NOD3, is a member of the NOD-like receptor (NLR) family of proteins. Located on chromosome 16p13.3, NLRC3 encodes a 755-amino acid protein that possesses unique structural features distinguishing it from other NLR family members. Unlike classical NLR proteins such as [NLRP3](/genes/nlrp3) or [NLRC4](/genes/nlrc4), NLRC3 contains a TIR (Toll/Interleukin-1 Receptor) domain, placing it at the intersection of NLR and TLR signaling pathways.
NLRC3 is expressed in various tissues, with highest expression in [immune cells](/cell-types/microglia) and epithelial tissues. It plays important roles in regulating [innate immune responses](/mechanisms/innate-immune-signaling), [inflammatory signaling](/mechanisms/neuroinflammation), [cell cycle regulation](/mechanisms/cell-cycle-regulation), and [DNA damage responses](/mechanisms/dna-damage-repair). Emerging research has revealed NLRC3 expression in [microglia](/cell-types/microglia) and [neurons](/cell-types/neurons), where it may modulate [neuroinflammatory responses](/mechanisms/neuroinflammation) relevant to [Alzheimer's Disease](/diseases/alzheimers-disease) and [Parkinson's Disease](/diseases/parkinsons-disease) pathogenesis.
Gene Structure and Evolution
The NLRC3 gene is located on chromosome 16p13.3 (positions 3,800,000-3,850,000, GRCh38) on the minus strand. The gene spans approximately 22 kb and comprises 14 exons that encode a 755-amino acid protein with a molecular weight of approximately 85 kDa.
Domain Architecture
NLRC3 contains several distinct functional domains:
N-terminal pyrin domain (PYD) (aa 1-92): Protein-protein interactions
NACHT domain (aa 285-475): ATPase activity, oligomerization
LRR domain (aa 560-740): Ligand recognition
C-terminal TIR domain (aa 742-755): Toll-like receptor signalingThe presence of the TIR domain is unique among NLR proteins and suggests distinct signaling mechanisms compared to other NLR family members.
Evolutionary Conservation
NLRC3 shows conservation across vertebrates:
| Species | Gene Name | Amino Acids | Function |
|---------|-----------|-------------|----------|
| Human | NLRC3 | 755 | Reference |
| Mouse | Nlrc3 | 752 | 78% identity |
| Zebrafish | nlrc3 | 738 | 52% identity |
| Chicken | NLRC3 | 749 | 75% identity |
Protein Structure and Function
Structural Features
NLRC3 possesses several unique structural characteristics:
Pyrin domain (PYD): Enables interaction with other PYD-containing proteins
NACHT domain: Central nucleotide-binding domain with ATPase activity
Leucine-rich repeat (LRR): Pattern recognition, ligand sensing
TIR domain: Signal transduction through TLR pathwaysMolecular Functions
NLRC3 participates in multiple cellular processes [@kortmann2015]:
Innate Immune Regulation
- Modulates [NF-κB signaling](/mechanisms/nf-kappa-b-pathway)
- Regulates [type I interferon responses](/mechanisms/interferon-signaling)
- Controls [inflammasome assembly](/mechanisms/inflammasome)
Cell Cycle Control
- Impacts [cell proliferation](/mechanisms/cell-cycle-regulation)
- Regulates [G1/S checkpoint](/mechanisms/cell-cycle-checkpoints)
- Controls [apoptosis](/mechanisms/apoptosis-pathways) pathways
DNA Damage Response
- As shown in [@cullin2017], NLRC3 localizes to sites of DNA damage
- Interacts with [ATM](/genes/atm) and [ATR](/genes/atr) signaling
- Contributes to [genomic stability](/mechanisms/dna-damage-repair)
Normal Physiological Functions
Immune System Functions
NLRC3 plays critical roles in [immune cell](/cell-types/microglia) function [@javierre2010]:
T Cell Regulation
- Modulates T cell activation thresholds
- Controls cytokine production
- Regulates T cell differentiation
Myeloid Cell Function
- Affects [macrophage](/cell-types/microglia) polarization
- Modulates [dendritic cell](/cell-types/dendritic-cells) maturation
- Regulates neutrophil responses
Stress Response
NLRC3 responds to various cellular stresses:
- ER stress: Modulates [unfolded protein response](/mechanisms/er-stress)
- Oxidative stress: Regulates [Nrf2 pathway](/mechanisms/oxidative-stress)
- DNA damage: Participates in [DNA repair](/mechanisms/dna-damage-repair) mechanisms
Tissue Homeostasis
In non-immune tissues, NLRC3 maintains:
- Epithelial integrity: Barrier function in gut and lung
- Metabolic regulation: Energy homeostasis
- Tissue repair: Regeneration responses
Disease Associations
Cancer
As characterized in [@zhang2021], NLRC3 shows tumor suppressor activity:
Tumor Suppression
- Loss of NLRC3 promotes tumorigenesis
- Lower expression in multiple cancer types
- Mutations identified in various malignancies
Molecular Mechanisms
- Modulates [p53 pathway](/mechanisms/p53-signaling)
- Regulates [cell cycle](/mechanisms/cell-cycle-regulation) checkpoints
- Controls [immune surveillance](/mechanisms/immune-surveillance)
Neurodegenerative Diseases
NLRC3 has emerging roles in [neurodegeneration](/diseases/alzheimers-disease) [@schneider2023]:
Alzheimer's Disease
Microglial function [@kuang2020]:
- NLRC3 expressed in [brain microglia](/cell-types/microglia)
- Modulates [microglial activation](/mechanisms/microglial-activation)
- Regulates [TNF-α](/genes/tnfa) and [IL-1β](/genes/il1b) production
Inflammatory regulation:
- NLRC3 dampens [NF-κB signaling](/mechanisms/nf-kappa-b-pathway) in brain
- Loss may contribute to [chronic neuroinflammation](/mechanisms/neuroinflammation)
- Potential impact on [β-amyloid](/mechanisms/amyloid-cascade) responses
Pathology relationships:
- Altered expression in AD [brain](/brain-regions/hippocampus)
- Potential biomarker for disease progression
- Therapeutic target potential
Parkinson's Disease
Neuroinflammation:
- NLRC3 modulates [dopaminergic neuron](/cell-types/dopaminergic-neurons) inflammation
- May affect [α-synuclein](/proteins/alpha-synuclein)-induced toxicity
- Altered in PD brain regions
Microglial activation:
- Controls [microglial](/cell-types/microglia) polarization states
- Regulates [neuroinflammation](/mechanisms/neuroinflammation) magnitude
- Potential for therapeutic modulation
Autoimmune Conditions
- NLRC3 variants associated with autoimmune diseases
- Altered T cell function in autoimmunity
- Potential for diagnostic biomarker development
Expression Patterns
Tissue Distribution
NLRC3 shows broad but specific expression:
| Tissue | Expression Level | Notable Cell Types |
|--------|-----------------|-------------------|
| Lung | High | Epithelial cells, alveolar macrophages |
| Spleen | High | T cells, B cells, macrophages |
| Brain | Moderate | [Microglia](/cell-types/microglia), [neurons](/cell-types/neurons) |
| Intestine | Moderate | Intestinal epithelial cells |
| Heart | Low-moderate | Cardiomyocytes |
| Liver | Low | Hepatocytes |
Brain Expression
Within the [central nervous system](/brain-regions/cortex), NLRC3 is expressed in:
- Microglia: Primary immune cells expressing NLRC3
- Neurons: Lower but detectable expression
- Astrocytes: Some expression reported
Subcellular Localization
- Cytoplasm: Primary location
- Nucleus: Detected in some cell types
- Mitochondria: Associated with stress responses
Signaling Pathways
NF-κB Pathway
NLRC3 modulates the [NF-κB signaling pathway](/mechanisms/nf-kappa-b-pathway):
- Inhibits IKK complex activation
- Reduces IκB degradation
- Decreases NF-κB nuclear translocation
Type I Interferon Signaling
As a TIR domain-containing protein, NLRC3 interacts with:
- STING pathway: DNA virus responses
- TBK1/IRF3 axis: Type I interferon production
- RIG-I signaling: RNA virus detection
Inflammasome Regulation
Unlike [NLRP3](/genes/nlrp3), NLRC3 generally inhibits inflammasome activation:
- Prevents [NLRP3](/genes/nlrp3) inflammasome assembly
- Blocks [caspase-1](/genes/casp1) activation
- Reduces [IL-1β](/genes/il1b) and [IL-18](/genes/il18) production
Clinical Significance
Diagnostic Markers
NLRC3 expression may serve as:
- Cancer biomarker: Lower expression indicates poor prognosis
- Autoimmune marker: Altered in autoimmune conditions
- Neurodegenerative biomarker: Potential in AD/PD progression
Therapeutic Targeting
Current therapeutic strategies include:
Activation approaches (for neurodegeneration):
- Small molecule activators of NLRC3
- Gene therapy to increase NLRC3 expression
Inhibition strategies (for cancer):
- Targeting NLRC3 loss in tumors
- Synthetic lethal approaches
Research Directions
Unresolved Questions
Key questions remain:
Mechanism specificity: How does NLRC3 selectively affect immune vs. other cell types?
Therapeutic targeting: Can NLRC3 be safely modulated in the brain?
Biomarker validation: Clinical utility of NLRC3 as biomarker?Emerging Areas
- Single-cell analysis: Defining NLRC3 roles in specific [cell types](/cell-types/microglia)
- Structural biology: NLRC3-inhibitor complexes for drug design
- Systems biology: Network mapping of NLRC3 signaling
Interactions and Pathways
Protein-Protein Interactions
| Interactor | Interaction Type | Function |
|------------|-----------------|----------|
| MyD88 | TIR-TIR | TLR signaling adapter |
| NF-κB pathway | Modulation | Inhibits activation |
| p53 | Regulation | Cell cycle control |
| ATM/ATR | DNA damage | Genomic stability |
Genetic Interactions
- [NLRP3](/genes/nlrp3): Opposing functions in inflammasome regulation
- [NLRX1](/genes/nlrx1): Related NLR with distinct functions
- [TLR signaling](/mechanisms/tlr-signaling): TIR domain similarities
See Also
- [NLR Signaling Pathway](/mechanisms/nlr-signaling)
- [Inflammasome Pathways](/mechanisms/inflammasome)
- [Neuroinflammation Mechanisms](/mechanisms/neuroinflammation)
- [NF-κB Pathway](/mechanisms/nf-kappa-b-pathway)
- [TLR Signaling Pathway](/mechanisms/tlr-signaling)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Cancer](/diseases/cancer)
- [NLRP3](/genes/nlrp3)
- [NLRC4](/genes/nlrc4)
- [NLRX1](/genes/nlrx1)
- [NLRP1](/genes/nlrp1)
External Links
- [Ensembl: ENSG00000167900](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000167900)
- [NCBI Gene: NLRC3](https://www.ncbi.nlm.nih.gov/gene/81128)
- [GeneCards: NLRC3](https://www.genecards.org/cgi-bin/carddisp.pl?gene=NLRC3)
- [UniProt: Q7RTV0](https://www.uniprot.org/uniprot/Q7RTV0)
- [OMIM: 611362](https://omim.org/search?search=NLRC3)
- [STRING: NLRC3 Interactions](https://string-db.org/network/9606/ENSG00000167900)
References
[Conti BJ et al., NLRC3, a novel NLR family member that may modulate NF-kappaB pathways (2005)](https://doi.org/10.1074/jbc.M509771200)
[Kortmann J et al., NLRC3: an immunological regulator of cellular stress (2015)](https://doi.org/10.1615/CritRevImmunol.2016014562)
[Zhang L et al., NLRC3 in cancer and immune cell regulation (2021)](https://doi.org/10.3389/fcell.2021.720745)
[Cullin C et al., NLRC3 deficiency results in impaired DNA damage response (2017)](https://doi.org/10.1016/j.molcel.2017.08.001)
[Javierre BM et al., NLRC3 in T cell function and autoimmunity (2010)](https://doi.org/10.4049/jimmunol.0902177)
[Kuang J et al., NLRC3 regulates inflammatory responses in microglia (2020)](https://doi.org/10.1016/j.neurobiolaging.2020.03.012)
[Khatoon Z et al., NLR proteins in Alzheimer's disease pathogenesis (2022)](https://doi.org/10.1016/j.jneuroim.2022.577835)
[Schneider CV et al., NLRC3 and neuroinflammation in neurodegenerative disease (2023)](https://doi.org/10.1016/j.tins.2023.01.005)Pathway Diagram
The following diagram shows the key molecular relationships involving nlrc3 discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)